<DOC>
	<DOCNO>NCT02706470</DOCNO>
	<brief_summary>The purpose study determine whether Cyclosporin A ( CsA ) - immunosuppressant drug - early pregnancy reduce risk miscarriage woman history unexplained recurrent miscarriage , compare treat Dydrogesterone-an active comparator . The hypothesis base evidence find vitro vivo experiment CsA induce maternal-fetal tolerance may reduce risk miscarriage .</brief_summary>
	<brief_title>Use Cyclosporin A Treatment Recurrent Miscarriage</brief_title>
	<detailed_description />
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Abortion , Habitual</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Dydrogesterone</mesh_term>
	<criteria>Both woman husband agree participate sign inform consent form . Have history two unexplained recurrent miscarriage . Spontaneous conception . Gestational age le 5 week . Have normal menstrual cycle ( &gt; =23 &lt; =35 day ) biphasic pattern basal body temperature pregnancy . No significant chromosomal aberration couple . Semen quality test show apparent abnormality husband Age 18 41 year conception . Present pregnancy result donor insemination egg donation . Significant uterine anomaly detect ultrasonography , hysterosalpingography , hysteroscopy . Contraindications CsA ( e.g . severe infectious disease , tumor immunodeficiency ) Dydrogesterone . Smoking 20 daily .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>recurrent miscarriage ; immunology</keyword>
</DOC>